An Examination of the Mechanisms and Treatments of Ciliopathies Triggered by Genes dlg5 and rnf20

Authors

  • Narayani Sakthinathan Plymouth Whitemarsh High School
  • Sakthinathan Pitchaiah

DOI:

https://doi.org/10.47611/jsrhs.v13i2.6733

Keywords:

Ciliopathies, rnf20, dlg5, ciliary mutations, laterality

Abstract

In the current society, ciliopathies continue, without fail, to impact a small, but existing portion of the public; classified as a genetic birth defect from mutations in ciliary genes, ciliopathies highly affect the younger generations, indicating an urgency for focus on progressive research in the field. Due to the vast number of possible genetic mutations, this paper centers on a select set of genetic mutations, dlg5 and rnf20, due to the varied amount of mutations that may be cause damage and the variety organs in the body that are impacted when the genes are mutated. The varied characteristics of each gene contribute to mutations developing a specific phenotype, depending on the ciliary aspect and tissue affected; this paper is sought to highlight the increased variability of ciliopathies. Current ciliopathy treatment methods are also investigated, identifying gaps existent and successes, focusing upon genetic therapy advances. Treatment methods are applied to dlg5 and rnf20, as the author proposes effective modes through which increased focus should be applied to devise treatments, in consideration with drawbacks that had been evident which finding treatments for general ciliopathies.

 

 

 

Downloads

Download data is not yet available.

Author Biography

Sakthinathan Pitchaiah

Sakthi Pitchaiah, has more than one decade diversified and comprehensive high-growth, high-complexity healthcare and life science data platforms experience, providing actionable data driven decision making insights across the healthcare industry and delivered high quality products in US Business markets. Always looking and solving complex healthcare real world challenges and problems through innovation and emerging technologies with the help of AI/ML, LLM and deep learning.

 

References or Bibliography

Devlin, L., Dhondurao Sudhindar, P., & Sayer, J. A. (2023). Renal ciliopathies: Promising drug targets and prospects for clinical trials. Expert Opinion on Therapeutic Targets, 27(4-5), 325-346. https://doi.org/10.1080/14728222.2023.2218616

Focșa, I., Budișteanu, M., & Bălgrădean, M. (2021). Clinical and genetic heterogeneity of primary ciliopathies (Review). International Journal of Molecular Medicine, 48(3). https://doi.org/10.3892/ijmm.2021.5009

Gallery. (n.d.). BioRender. Retrieved May 26, 2023, from

https://www.biorender.com/

Hierck, B. P., & Van der Heiden, K. (2011). Role for Primary Cilia as Flow Detectors in the Cardiovascular System. ScienceDirect. Retrieved May 12, 2023, from https://www.sciencedirect.com/topics/neuroscience/ciliopathy

Marquez, J., Mann, N., Arana, K., Deniz, E., Ji, W., Konstantino, M., Mis, E. K., Deshpande, C., Jeffries, L., McGlynn, J., Hugo, H., Widmeier, E., Konrad, M., Tasic, V., Morotti, R., Baptista, J., Ellard, S., Lakhani, S. A., Hildebrandt, F., & Khokha, M. K. (2020). DLG5 variants are associated with multiple congenital anomalies including ciliopathy phenotypes. Journal of Medical Genetics, 58(7), 453-464. https://doi.org/10.1136/jmedgenet-2019-106805

McIntyre, J. C., Williams, C. L., & Martens, J. R. (2013). Smelling the roses and seeing the light: Gene therapy for ciliopathies. Trends in Biotechnology, 31(6), 355-363. https://doi.org/10.1016/j.tibtech.2013.03.005

NIH researchers develop gene therapy for rare ciliopathy. (2022, September 8). National Eye Institute. Retrieved May 12, 2023, from https://www.nei.nih.gov/about/news-and-events/news/nih-researchers-develop-gene-therapy-rare-ciliopathy

Rare Disease Day 2018: The Importance of Funding and Research. (2018, February

. The MSA Coalition. Retrieved May 12, 2023, from https://www.multiplesystematrophy.org/uncategorized/rare-disease-day-2018-importance-funding-research/#:~:text=Diseases%20that%20impact%20a%20greater,clinical%20trials%20available%20to%20patients.

Robson, A., Makova, S. Z., Barish, S., Zaidi, S., Mehta, S., Drozd, J., Jin, S. C., Gelb, B. D., Seidman, C. E., Chung, W. K., Lifton, R. P., Khokha, M. K., & Brueckner, M. (2019). Histone h2b monoubiquitination regulates heart development via epigenetic control of cilia motility. Proceedings of the National Academy of Sciences, 116(28), 14049-14054. https://doi.org/10.1073/pnas.1808341116

Satir, P. (2017, March 8). CILIA: before and after. National Library of Medicine. Retrieved July 9, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343305/#:~:text=Cilia%20are%20the%20oldest%20known,5%2C%20because%20of%20their%20motility.

Stokman, M. F., Saunier, S., & Benmerah, A. (2021, may 13). Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis. frontiers. Retrieved May 12, 2023, from https://www.frontiersin.org/articles/10.3389/fcell.2021.653138/full

Zhang, Y., Chen, W., Zeng, W., Lu, Z., & Zhou, X. (2020). Biallelic loss of function nek3 mutations deacetylate α-tubulin and downregulate nup205 that predispose individuals to cilia-related abnormal cardiac left–right patterning. Cell Death & Disease, 11(11). https://doi.org/10.1038/s41419-020-03214-1

Published

05-31-2024

How to Cite

Sakthinathan, N., & Pitchaiah, S. (2024). An Examination of the Mechanisms and Treatments of Ciliopathies Triggered by Genes dlg5 and rnf20 . Journal of Student Research, 13(2). https://doi.org/10.47611/jsrhs.v13i2.6733

Issue

Section

HS Review Articles